Free Trial

MarketBeat Instant News Alerts

GAP logo with Retail/Wholesale background

GAP (NYSE:GAP) Price Target Lowered to $24.00 at Telsey Advisory Group

Telsey Advisory Group dropped their target price on shares of GAP from $26.00 to $24.00 and set a "market perform" rating for the company in a report on Tuesday.

NYSE:GAP
Read GAP (NYSE:GAP) Price Target Lowered to $24.00 at Telsey Advisory Group
Ulta Beauty logo with Retail/Wholesale background

Telsey Advisory Group Boosts Ulta Beauty (NASDAQ:ULTA) Price Target to $610.00

Telsey Advisory Group lifted their price objective on shares of Ulta Beauty from $590.00 to $610.00 and gave the company an "outperform" rating in a research note on Tuesday.

NASDAQ:ULTA
Read Telsey Advisory Group Boosts Ulta Beauty (NASDAQ:ULTA) Price Target to $610.00
Ithaca Energy logo with Energy background

Shore Capital Reaffirms "No Recommendation" Rating for Ithaca Energy (LON:ITH)

Shore Capital reissued a "no recommendation" rating on shares of Ithaca Energy in a report on Tuesday.

LON:ITH
Read Shore Capital Reaffirms "No Recommendation" Rating for Ithaca Energy (LON:ITH)
Burberry Group logo with Consumer Cyclical background

Burberry Group (LON:BRBY) Receives Buy Rating from HSBC

HSBC restated a "buy" rating and set a GBX 1,600 target price on shares of Burberry Group in a report on Tuesday.

LON:BRBY
Read Burberry Group (LON:BRBY) Receives Buy Rating from HSBC
Atara Biotherapeutics logo with Medical background

Vestal Point Capital LP Has $559,000 Position in Atara Biotherapeutics, Inc. $ATRA

Vestal Point Capital LP cut its holdings in Atara Biotherapeutics, Inc. (NASDAQ:ATRA - Free Report) by 24.7% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 94,085 shares of the biotechnology company's stock after sel

NASDAQ:ATRA
Read Vestal Point Capital LP Has $559,000 Position in Atara Biotherapeutics, Inc. $ATRA
Alector logo with Medical background

504,540 Shares in Alector, Inc. $ALEC Acquired by Vestal Point Capital LP

Vestal Point Capital LP acquired a new stake in Alector, Inc. (NASDAQ:ALEC - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 504,540 shares of the company's stock, valued at approximately $6

NASDAQ:ALEC
Read 504,540 Shares in Alector, Inc. $ALEC Acquired by Vestal Point Capital LP

Trending News

All MarketBeat Instant News Alerts

Arcturus Therapeutics logo with Medical background

Vestal Point Capital LP Invests $2.24 Million in Arcturus Therapeutics Holdings Inc. $ARCT

NASDAQ:ARCT
Read Vestal Point Capital LP Invests $2.24 Million in Arcturus Therapeutics Holdings Inc. $ARCT
Celldex Therapeutics logo with Medical background

Vestal Point Capital LP Decreases Stock Position in Celldex Therapeutics, Inc. $CLDX

NASDAQ:CLDX
Read Vestal Point Capital LP Decreases Stock Position in Celldex Therapeutics, Inc. $CLDX
Kiniksa Pharmaceuticals International logo with Medical background

Vestal Point Capital LP Invests $3.77 Million in Kiniksa Pharmaceuticals International, plc $KNSA

NASDAQ:KNSA
Read Vestal Point Capital LP Invests $3.77 Million in Kiniksa Pharmaceuticals International, plc $KNSA
Lexeo Therapeutics logo with Medical background

Vestal Point Capital LP Cuts Stock Position in Lexeo Therapeutics, Inc. $LXEO

NASDAQ:LXEO
Read Vestal Point Capital LP Cuts Stock Position in Lexeo Therapeutics, Inc. $LXEO
Zymeworks logo with Medical background

Zymeworks Inc. $ZYME Shares Acquired by Vestal Point Capital LP

NYSE:ZYME
Read Zymeworks Inc. $ZYME Shares Acquired by Vestal Point Capital LP
Immunovant logo with Medical background

Vestal Point Capital LP Buys 305,000 Shares of Immunovant, Inc. $IMVT

NASDAQ:IMVT
Read Vestal Point Capital LP Buys 305,000 Shares of Immunovant, Inc. $IMVT
Solid Biosciences logo with Medical background

Vestal Point Capital LP Sells 1,096,442 Shares of Solid Biosciences Inc. $SLDB

NASDAQ:SLDB
Read Vestal Point Capital LP Sells 1,096,442 Shares of Solid Biosciences Inc. $SLDB
MoonLake Immunotherapeutics logo with Medical background

Vestal Point Capital LP Acquires Shares of 200,000 MoonLake Immunotherapeutics $MLTX

NASDAQ:MLTX
Read Vestal Point Capital LP Acquires Shares of 200,000 MoonLake Immunotherapeutics $MLTX
Cidara Therapeutics logo with Medical background

Vestal Point Capital LP Acquires Shares of 504,542 Cidara Therapeutics, Inc. $CDTX

NASDAQ:CDTX
Read Vestal Point Capital LP Acquires Shares of 504,542 Cidara Therapeutics, Inc. $CDTX
Bruker logo with Computer and Technology background

Vestal Point Capital LP Takes $12.52 Million Position in Bruker Corporation $BRKR

NASDAQ:BRKR
Read Vestal Point Capital LP Takes $12.52 Million Position in Bruker Corporation $BRKR
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics, Inc. $SRPT Shares Sold by Vestal Point Capital LP

NASDAQ:SRPT
Read Sarepta Therapeutics, Inc. $SRPT Shares Sold by Vestal Point Capital LP
Nurix Therapeutics logo with Medical background

Vestal Point Capital LP Has $13.37 Million Stock Position in Nurix Therapeutics, Inc. $NRIX

NASDAQ:NRIX
Read Vestal Point Capital LP Has $13.37 Million Stock Position in Nurix Therapeutics, Inc. $NRIX
Globus Medical logo with Medical background

Vestal Point Capital LP Trims Stock Position in Globus Medical, Inc. $GMED

NYSE:GMED
Read Vestal Point Capital LP Trims Stock Position in Globus Medical, Inc. $GMED
Nyxoah logo with Medical background

Vestal Point Capital LP Sells 605,262 Shares of Nyxoah SA $NYXH

NASDAQ:NYXH
Read Vestal Point Capital LP Sells 605,262 Shares of Nyxoah SA $NYXH
GE HealthCare Technologies logo with Medical background

Vestal Point Capital LP Makes New $16.48 Million Investment in GE HealthCare Technologies Inc. $GEHC

NASDAQ:GEHC
Read Vestal Point Capital LP Makes New $16.48 Million Investment in GE HealthCare Technologies Inc. $GEHC
Perrigo logo with Medical background

Vestal Point Capital LP Grows Stock Holdings in Perrigo Company plc $PRGO

NYSE:PRGO
Read Vestal Point Capital LP Grows Stock Holdings in Perrigo Company plc $PRGO
Verona Pharma PLC American Depositary Share logo with Medical background

Vestal Point Capital LP Sells 227,373 Shares of Verona Pharma PLC American Depositary Share $VRNA

NASDAQ:VRNA
Read Vestal Point Capital LP Sells 227,373 Shares of Verona Pharma PLC American Depositary Share $VRNA
Establishment Labs logo with Medical background

Vestal Point Capital LP Grows Stock Holdings in Establishment Labs Holdings Inc. $ESTA

NASDAQ:ESTA
Read Vestal Point Capital LP Grows Stock Holdings in Establishment Labs Holdings Inc. $ESTA
Cogent Biosciences logo with Medical background

Vestal Point Capital LP Invests $17.97 Million in Cogent Biosciences, Inc. $COGT

NASDAQ:COGT
Read Vestal Point Capital LP Invests $17.97 Million in Cogent Biosciences, Inc. $COGT
Liquidia Technologies logo with Medical background

Vestal Point Capital LP Has $18.10 Million Stock Holdings in Liquidia Technologies, Inc. $LQDA

NASDAQ:LQDA
Read Vestal Point Capital LP Has $18.10 Million Stock Holdings in Liquidia Technologies, Inc. $LQDA
Ultragenyx Pharmaceutical logo with Medical background

Ultragenyx Pharmaceutical Inc. $RARE Shares Sold by Vestal Point Capital LP

NASDAQ:RARE
Read Ultragenyx Pharmaceutical Inc. $RARE Shares Sold by Vestal Point Capital LP
Dyne Therapeutics logo with Medical background

1,800,000 Shares in Dyne Therapeutics, Inc. $DYN Purchased by Vestal Point Capital LP

NASDAQ:DYN
Read 1,800,000 Shares in Dyne Therapeutics, Inc. $DYN Purchased by Vestal Point Capital LP
Day One Biopharmaceuticals logo with Medical background

Vestal Point Capital LP Buys 1,158,127 Shares of Day One Biopharmaceuticals, Inc. $DAWN

NASDAQ:DAWN
Read Vestal Point Capital LP Buys 1,158,127 Shares of Day One Biopharmaceuticals, Inc. $DAWN
Ascendis Pharma A/S logo with Medical background

Vestal Point Capital LP Lowers Stock Position in Ascendis Pharma A/S $ASND

NASDAQ:ASND
Read Vestal Point Capital LP Lowers Stock Position in Ascendis Pharma A/S $ASND

Featured Articles and Offers

Sector News